Halloween Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Latest Stock Buy or Sell? Make More Informed Decisions!

Today, The Weekly Buzzing Stocks by Billy Kawasaki and The Panic-Proof Portfolio (Stockchase Research) commented about whether IBIT, BAM.TO, CDWC, META, AGI.TO, APLD are stocks to buy or sell.

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

In the last quarter, the company reported 0.84 CAD per share, beating the 0.75 CAD estimate by 11.91%. Revenue for the same period reached 843.89 M CAD, despite the estimate of 843.16 M CAD. For the next quarter, analysts expect 0.68 CAD in earnings per share and 753.25 M CAD in revenue. Social media mentions are up 600% in the past 24h.

premiumPremium content

🔒 Premium Content Alert – This buzzing stock opinion is accessible only to Stockchase Premium

Discover an exclusive list and analysis of the stocks that are trending on social medias—accessible only to our Premium subscribers. With a keen focus on the stocks that are setting social media ablaze, this weekly feature offers an invaluable lens through which to evaluate market movers. Say goodbye to the endless scroll through social media timelines; we curate the buzz so you can invest your time as wisely as your money. Unlock Premium Now.

TOP PICK

In the last quarter, the company reported 6.18 USD per share, beating the 7.19 USD estimate by -14.02%. Revenue for the same period reached 60.80 B USD, despite the estimate of 60.22 B USD. For the next quarter, analysts expect 6.77 USD in earnings per share and 63.28 B USD in revenue. Social media mentions are up 186% in the past 24h.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

CDW provides IT solutions to companies, government, healthcare and education groups in US, the UK, and Canada.  It recently acquired a AI consulting specialist that will grow their ability for a one-stop solution for companies to maximize its IT investment.  It trades at 17x earnings and supports a robust 44% ROE.  It has prudently reduced some cash reserves to aggressively buy back shares.  We recommend setting a stop-loss at $121, looking to achieve $163 -- upside potential of 18%.  Yield 1.8%

(Analysts’ price target is $158.67)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

BAM manages over $1.2 trillion USD in infrastructure assets, operating like a diversified portfolio with revenues originating from the Americas, European markets and Asia-Pacific.  Threats of rising interest rates have pulled the shares down recently.  Revenues last year grew by 32% and income by 42%.  It trades at 26x earnings and supports a 35% ROE.  We recommend setting a stop-loss at $52, looking to achieve $80 -- upside potential of 18%.  Yield 3.1%

(Analysts’ price target is $80.10)
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly

We reiterate this ETF, which allows investors to participate directly in bitcoin, as a TOP PICK.   Upward momentum we look for has been encouragin in line with optimistic US economic growth outlooks.  We recommend trailing up the stop (from $34) to $38, looking to achieve $55 -- upside potential of 18%.  Yield 0%